205 related articles for article (PubMed ID: 32599088)
1. Anti-glomerular basement membrane disease during the COVID-19 pandemic.
Prendecki M; Clarke C; Cairns T; Cook T; Roufosse C; Thomas D; Willicombe M; Pusey CD; McAdoo SP
Kidney Int; 2020 Sep; 98(3):780-781. PubMed ID: 32599088
[No Abstract] [Full Text] [Related]
2. What about the original antigenic sin of the humans versus SARS-CoV-2?
Roncati L; Palmieri B
Med Hypotheses; 2020 Sep; 142():109824. PubMed ID: 32408068
[No Abstract] [Full Text] [Related]
3. Cellular immune responses to covid-19.
Sewell HF; Agius RM; Stewart M; Kendrick D
BMJ; 2020 Jul; 370():m3018. PubMed ID: 32737031
[No Abstract] [Full Text] [Related]
4. Coronavirus vaccines get a biotech boost.
Dance A
Nature; 2020 Jul; 583(7817):647-649. PubMed ID: 32694847
[No Abstract] [Full Text] [Related]
5. A COVID-19 Patient with Repeatedly Undetectable SARS-CoV-2 Antibodies.
Goetz L; Yang J; Greene W; Zhu Y
J Appl Lab Med; 2020 Nov; 5(6):1401-1405. PubMed ID: 32745181
[No Abstract] [Full Text] [Related]
6. SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines.
Salvatori G; Luberto L; Maffei M; Aurisicchio L; Roscilli G; Palombo F; Marra E
J Transl Med; 2020 Jun; 18(1):222. PubMed ID: 32493510
[TBL] [Abstract][Full Text] [Related]
7. Antibody responses to SARS-CoV-2 in patients with differing severities of coronavirus disease 2019.
Kowitdamrong E; Puthanakit T; Jantarabenjakul W; Prompetchara E; Suchartlikitwong P; Putcharoen O; Hirankarn N
PLoS One; 2020; 15(10):e0240502. PubMed ID: 33035234
[TBL] [Abstract][Full Text] [Related]
8. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 and the Path to Immunity.
Stephens DS; McElrath MJ
JAMA; 2020 Oct; 324(13):1279-1281. PubMed ID: 32915201
[No Abstract] [Full Text] [Related]
10. Active Therapy with Passive Immunotherapy May Be Effective in the Fight against COVID-19.
Morabito CJ; Gangadharan B
Clin Transl Sci; 2020 Sep; 13(5):835-837. PubMed ID: 32420691
[No Abstract] [Full Text] [Related]
11. Persistent COVID-19 Pneumonia and Failure to Develop Anti-SARS-CoV-2 Antibodies During Rituximab Maintenance Therapy for Follicular Lymphoma.
Yasuda H; Tsukune Y; Watanabe N; Sugimoto K; Uchimura A; Tateyama M; Miyashita Y; Ochi Y; Komatsu N
Clin Lymphoma Myeloma Leuk; 2020 Nov; 20(11):774-776. PubMed ID: 32933879
[No Abstract] [Full Text] [Related]
12. COVID-19 in Africa: Dampening the storm?
Mbow M; Lell B; Jochems SP; Cisse B; Mboup S; Dewals BG; Jaye A; Dieye A; Yazdanbakhsh M
Science; 2020 Aug; 369(6504):624-626. PubMed ID: 32764055
[No Abstract] [Full Text] [Related]
13. Analysis of adjunctive serological detection to nucleic acid test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis.
Liu R; Liu X; Yuan L; Han H; Shereen MA; Zhen J; Niu Z; Li D; Liu F; Wu K; Luo Z; Zhu C
Int Immunopharmacol; 2020 Sep; 86():106746. PubMed ID: 32619956
[TBL] [Abstract][Full Text] [Related]
14. Recovered COVID-19 patients with recurrent viral RNA exhibit lower levels of anti-RBD antibodies.
Liu B; Shi Y; Zhang W; Li R; He Z; Yang X; Pan Y; Deng X; Tan M; Zhao L; Zou F; Zhang Y; Pan T; Zhang J; Zhang X; Xiao F; Li F; Deng K; Zhang H
Cell Mol Immunol; 2020 Oct; 17(10):1098-1100. PubMed ID: 32939033
[No Abstract] [Full Text] [Related]
15. S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit.
Nguyen-Contant P; Embong AK; Kanagaiah P; Chaves FA; Yang H; Branche AR; Topham DJ; Sangster MY
mBio; 2020 Sep; 11(5):. PubMed ID: 32978311
[TBL] [Abstract][Full Text] [Related]
16. The explosion of new coronavirus tests that could help to end the pandemic.
Guglielmi G
Nature; 2020 Jul; 583(7817):506-509. PubMed ID: 32681157
[No Abstract] [Full Text] [Related]
17. What Would Jenner and Pasteur Have Done About COVID-19 Coronavirus? The Urges of a Vaccinologist.
Palatnik-de-Sousa CB
Front Immunol; 2020; 11():2173. PubMed ID: 32983183
[No Abstract] [Full Text] [Related]
18. Evaluation of an Electrochemiluminescent SARS-CoV-2 Antibody Assay.
Lau CS; Hoo SP; Yew SF; Ong SK; Lum LT; Heng PY; Tan JG; Wong MS; Aw TC
J Appl Lab Med; 2020 Nov; 5(6):1313-1323. PubMed ID: 32717060
[TBL] [Abstract][Full Text] [Related]
19. Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate.
Addetia A; Crawford KHD; Dingens A; Zhu H; Roychoudhury P; Huang ML; Jerome KR; Bloom JD; Greninger AL
J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32826322
[TBL] [Abstract][Full Text] [Related]
20. New insights in COVID-19-associated chilblains: A comparative study with chilblain lupus erythematosus.
Battesti G; El Khalifa J; Abdelhedi N; Ferre V; Bouscarat F; Picard-Dahan C; Brunet-Possenti F; Collin G; Lavaud J; Le Bozec P; Rousselot M; Tournier A; Lheure C; Couvelard A; Hacein-Bey-Abina S; Abina AM; Charpentier C; Mignot S; Nicaise P; Descamps D; Deschamps L; Descamps V
J Am Acad Dermatol; 2020 Oct; 83(4):1219-1222. PubMed ID: 32622895
[No Abstract] [Full Text] [Related]
[Next] [New Search]
